​​​​​​​​​​​​​​​​​​​​​This Device​​​​ Eva​luation webcast is being made available to the general public. Con​​tact us to learn abou​​t everything the Device Evaluation group can do for your organization.​​

This webcas​t was h​eld on October 26, 2022. A recording of the event appears below.

Ove​​rview​

Ventilator-associated pneumonia (VAP) is a serious and common complication for patients requiring multiple days of respiratory support. ECRI has reviewed the clinical evidence for a technology that may help reduce VAP incidence—endotracheal tubes fitted with subglottic secretion drainage ports—and is currently testing several devices in the lab. Watch a recording of our October 2022 webcast, which covered current strategies to reduce VAP, the evidence su​pporting use of subglottic drainage to prevent VAP, and ECRI's hands-on lab testing of subglottic drainage technology. ​

Pre​​s​​enters

• Jason Launders, Director of Operations, Device Evaluation, ECRI
• Ericka Kalp, PhD, MPH, CIC, FAPIC, Director of Consulting, PSRQ Risk Management Contracts, ECRI
• Savvas Pavlides, PhD, Senior Manager, Scientific Quality, Clinical Evidence-Genetic Test Assessment, ECRI
• Kathy Punzo, Senior Project Officer, Device Evaluation, ECRI
• Ismael Cordero, Senior Project Officer, Device Evaluation, ECRI​

WEBCAST RE​​CORDING

SUPPLEMENTARY MATERIALS

​Key Takeaways​

Webcast Poll Results​​

ECRI Resources​​

Clinical Evi​dence Assessment 

Endotracheal Tubes with Subglottic Secretion Drainage Ports for Preventing Ventilator-associated Pneumonia​

​​​Guidance Articles

Medical S​​uction Devices: Using Them S​afely and Effectively

Ventilator Safety and Ethics​